Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYTARABINE Cause Deep vein thrombosis? 207 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 207 reports of Deep vein thrombosis have been filed in association with CYTARABINE (cytarabine). This represents 0.5% of all adverse event reports for CYTARABINE.

207
Reports of Deep vein thrombosis with CYTARABINE
0.5%
of all CYTARABINE reports
18
Deaths
84
Hospitalizations

How Dangerous Is Deep vein thrombosis From CYTARABINE?

Of the 207 reports, 18 (8.7%) resulted in death, 84 (40.6%) required hospitalization, and 15 (7.2%) were considered life-threatening.

Is Deep vein thrombosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 207 reports have been filed with the FAERS database.

What Other Side Effects Does CYTARABINE Cause?

Febrile neutropenia (6,142) Off label use (4,183) Pyrexia (2,992) Neutropenia (2,558) Disease progression (2,352) Drug ineffective (2,281) Thrombocytopenia (2,148) Sepsis (2,013) Myelosuppression (1,869) Product use in unapproved indication (1,619)

What Other Drugs Cause Deep vein thrombosis?

LENALIDOMIDE (3,286) RIVAROXABAN (3,180) TESTOSTERONE (2,213) APIXABAN (1,944) ETHINYL ESTRADIOL\ETONOGESTREL (1,577) RITUXIMAB (1,287) METHOTREXATE (1,146) DROSPIRENONE\ETHINYL ESTRADIOL (1,139) DEXAMETHASONE (1,067) ADALIMUMAB (1,056)

Which CYTARABINE Alternatives Have Lower Deep vein thrombosis Risk?

CYTARABINE vs CYTARABINE\DAUNORUBICIN CYTARABINE vs DABIGATRAN CYTARABINE vs DABIGATRAN ETEXILATE CYTARABINE vs DABRAFENIB CYTARABINE vs DABRAFENIB\TRAMETINIB

Related Pages

CYTARABINE Full Profile All Deep vein thrombosis Reports All Drugs Causing Deep vein thrombosis CYTARABINE Demographics